Optiver Holding B.V. Nanobiotix S.A. Transaction History
Optiver Holding B.V.
- $6 Billion
- Q3 2025
A detailed history of Optiver Holding B.V. transactions in Nanobiotix S.A. stock. As of the latest transaction made, Optiver Holding B.V. holds 5,356 shares of NBTX stock, worth $112,315. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,356Holding current value
$112,315% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBTX
# of Institutions
12Shares Held
5.89MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$118 Million8.95% of portfolio
-
Black Rock Inc. New York, NY239KShares$5.01 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA10.2KShares$213,5580.0% of portfolio
-
Morgan Stanley New York, NY5.3KShares$111,1410.0% of portfolio
-
Ubs Group Ag4.42KShares$92,6450.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $731M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...